TGF-β has been found to sustain renal disease progression to fibrosis also by driving tubular atrophy, podocyte depletion, and loss of capillary endothelial cells [30], with consequent tubular hypoxia and hypoxic-mediated fibrogenesis. Here, TGFB1 is linked to kidney disorder.